American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Organizations

Organizations

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Meda Pharmaceuticals


Medac Inc.


Medac Pharma, Inc


Medimpact Healthcare Systems, Inc.


Medivation, Inc.


Merck


Mylan Inc.


National Center for Policy Analysis


National Institute of Allergy and Infectious Diseases (NIAID)


National Institutes Of Health


National Science And Technology Council (NTSC)


Novartis Corporation


Noven Pharmaceuticals, Inc.


Novo Nordisk Inc.


Obi Pharma, Inc.


Onconova Therapeutics


Optum, Inc.


Optumrx, Inc.


Orexo Us, Inc.


Otsuka America Pharmaceutical, Inc.


  • «
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • »
Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'

Elise Shutzer, Vice President of Public Affairs at PhRMA

PhRMA launches 'Goldmine: Spa Day' campaign targeting 340B hospital drug pricing program

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Paul Gigot, Editor-in-chief, Wall Street Journal

WSJ Editorial Board says 340B program has been exploited following North Dakota ruling

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up